...
首页> 外文期刊>Iranian Journal of Basic Medical Sciences >BACTERIOPHAGE: TIME TO RE-EVALUATE THE POTENTIAL OF PHAGE THERAPY AS A PROMISING AGENT TO CONTROL MULTIDRUG-RESISTANT BACTERIA
【24h】

BACTERIOPHAGE: TIME TO RE-EVALUATE THE POTENTIAL OF PHAGE THERAPY AS A PROMISING AGENT TO CONTROL MULTIDRUG-RESISTANT BACTERIA

机译:细菌噬菌体:是时候重新评估噬菌体治疗的潜力,作为控制多药耐药菌的有希望的代理商

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Nowadays the most difficult problem in treatment of bacterial infections is the appearance of resistant bacteria to the antimicrobial agents so that the attention is being drawn to other potential targets. In view of the positive findings of phage therapy, many advantages have been mentioned which utilizes phage therapy over chemotherapy and it seems to be a promising agent to replace the antibiotics. This review focuses on an understanding of phages for the treatment of bacterial infectious diseases as a new alternative treatment of infections caused by multiple antibiotic resistant bacteria. Therefore, utilizing bacteriophage may be accounted as an alternative therapy. It is appropriate time to re-evaluate the potential of phage therapy as an effective bactericidal and a promising agent to control multidrug-resistant bacteria.
机译:如今,在治疗细菌感染中最困难的问题是对抗菌剂产生抗药性,因此引起了人们对其他潜在目标的关注。鉴于噬菌体疗法的积极发现,已经提到利用噬菌体疗法优于化学疗法的许多优点,并且它似乎是替代抗生素的有前途的药剂。这篇综述着重于噬菌体作为细菌感染性疾病的治疗方法的理解,这是一种由多种抗生素抗性细菌引起的感染的新型替代治疗方法。因此,利用噬菌体可以被认为是替代疗法。现在是时候重新评估噬菌体疗法作为有效杀菌剂和控制多药耐药细菌的有前途潜力的潜力了。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号